Cardiovascular Systems, Inc.
CSII · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $236 | $259 | $237 | $248 |
| % Growth | -8.8% | 9.5% | -4.6% | – |
| Cost of Goods Sold | $63 | $61 | $49 | $48 |
| Gross Profit | $173 | $198 | $188 | $200 |
| % Margin | 73.1% | 76.4% | 79.4% | 80.8% |
| R&D Expenses | $37 | $41 | $43 | $33 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $171 | $167 | $170 | $168 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $168 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $209 | $210 | $215 | $201 |
| Operating Income | -$36 | -$12 | -$27 | -$1 |
| % Margin | -15.2% | -4.6% | -11.3% | -0.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | $1 |
| Pre-Tax Income | -$37 | -$13 | -$27 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$37 | -$13 | -$27 | -$0 |
| % Margin | -15.6% | -5.2% | -11.5% | -0.1% |
| EPS | -0.94 | -0.35 | -0.79 | -0.008 |
| % Growth | -168.6% | 55.7% | -10,294.7% | – |
| EPS Diluted | -0.94 | -0.35 | -0.79 | -0.008 |
| Weighted Avg Shares Out | 39 | 39 | 34 | 34 |
| Weighted Avg Shares Out Dil | 39 | 39 | 34 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $2 | $2 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $3 |
| EBITDA | -$34 | -$10 | -$24 | $5 |
| % Margin | -14.2% | -3.9% | -10.1% | 2% |